#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1655024	F	Antibacterial activity against Helicobacter pylori SS1 by CLSI M100-S13 method	Helicobacter pylori	7	ALA1649516	organism-based format	Scientific Literature
2.	ALA1655025	F	Antibacterial activity against Helicobacter pylori ARHp80 by CLSI M100-S13 method	Helicobacter pylori	7	ALA1649516	organism-based format	Scientific Literature
3.	ALA1655026	B	Inhibition of MurI in flaA mutant Helicobacter pylori Hp80.2 overexpressing MurI gene assessed as microbial growth inhibition by CLSI M100-S13 method	Helicobacter pylori	7	ALA1649516	single protein format	Scientific Literature
4.	ALA1655027	F	Antibacterial activity against HefC-deficient Helicobacter pylori ARHp80 by CLSI M100-S13 method	Helicobacter pylori	7	ALA1649516	organism-based format	Scientific Literature
5.	ALA1655028	F	Antibacterial activity against Escherichia coli by CLSI M100-S13 method	Escherichia coli	7	ALA1649516	organism-based format	Scientific Literature
6.	ALA1655029	F	Antibacterial activity against Staphylococcus aureus by CLSI M100-S13 method	Staphylococcus aureus	7	ALA1649516	organism-based format	Scientific Literature
7.	ALA2092116	B	Inhibition of Helicobacter pylori J99 glutamate racemase	Helicobacter pylori J99	49	ALA2086265	single protein format	Scientific Literature
8.	ALA2092117	F	Antibacterial activity against wild type Helicobacter pylori 055	Helicobacter pylori	49	ALA2086265	organism-based format	Scientific Literature
9.	ALA2092118	F	Antibacterial activity against AcrAB-TolC efflux pump-dificient Helicobacter pylori	Helicobacter pylori	38	ALA2086265	organism-based format	Scientific Literature
10.	ALA2092119	A	Intrinsic clearance in human liver microsomes at 2 uM assessed per mg of protein	Homo sapiens	46	ALA2086265	microsome format	Scientific Literature
11.	ALA2092120	A	Intrinsic clearance in mouse liver microsomes at 2 uM assessed per mg of protein	Mus musculus	46	ALA2086265	microsome format	Scientific Literature
12.	ALA2092125	A	Clearance in mouse at 5 mg/kg, iv and 40 mg/kg, po	Mus musculus	3	ALA2086265	organism-based format	Scientific Literature
13.	ALA2092126	A	Half life in mouse at 5 mg/kg, iv and 40 mg/kg, po	Mus musculus	2	ALA2086265	organism-based format	Scientific Literature
14.	ALA2092127	A	Volume of distribution at steady state in mouse at 5 mg/kg, iv and 40 mg/kg, po	Mus musculus	2	ALA2086265	organism-based format	Scientific Literature
15.	ALA2092128	A	Plasma protein binding in mouse at 10 uM after 16 hrs by Dianorm method	Mus musculus	2	ALA2086265	cell-free format	Scientific Literature
16.	ALA2092129	P	Dissociation constant, pKa of the compound		1	ALA2086265	small-molecule physicochemical format	Scientific Literature
17.	ALA2092130	F	Antibacterial activity against Helicobacter pylori infected in mouse assessed as log reduction CFU at 40 mg/kg administered QD for 2 days relative to untreated control	Helicobacter pylori	1	ALA2086265	organism-based format	Scientific Literature
18.	ALA2092133	A	Oral bioavailability in mouse at 40 mg/kg	Mus musculus	3	ALA2086265	organism-based format	Scientific Literature
19.	ALA3301362	P	ASTRAZENECA: Most basic pKa value (pKa B1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Bases: >= 2.		261	ALA3301361	small-molecule physicochemical format	AstraZeneca Deposited Data
20.	ALA3301363	P	ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5		4,197	ALA3301361	small-molecule physicochemical format	AstraZeneca Deposited Data